Amarin's Legal Appeal Part I - An Introductory Article Discussing Timeline And Valuation ScenariosSeeking Alpha • 05/18/20
VASCEPA® (icosapent ethyl) Shows Significant Reduction in Coronary Revascularization, Including Coronary Stenting and Cardiac Bypass Surgery, in Prespecified and Post Hoc Analyses of Landmark REDUCE-IT® StudyGlobeNewsWire • 05/14/20
Amarin Corporation plc (AMRN) CEO John Thero on Q1 2020 Update - Earnings Call TranscriptSeeking Alpha • 04/30/20
Amarin Corporation plc (AMRN) CEO John Thero on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 04/14/20
Amarin Corportion Plc: Now Compelling On Ex-U.S. Opportunity And Potential Barriers To Generic CompetitionSeeking Alpha • 04/06/20